Eveglip-M Tablet
Eveglip-M Tablet
Metformin (500mg) + Vildagliptin (50mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Evglip-M Tablet: A Combined Therapy for Type 2 Diabetes
Evglip-M Tablet combines the proven efficacy of Metformin (500mg) with the precise action of Vildagliptin (5mg), delivering a comprehensive approach to managing type 2 diabetes. This synergistic combination targets both insulin resistance and incretin hormone deficiency, leading to improved blood glucose control in adults.
Benefits:
* Enhanced Insulin Sensitivity: Metformin improves cellular response to insulin, reducing blood sugar levels.
* Increased Incretins: Vildagliptin enhances the body's natural release of incretin hormones, further lowering blood sugar after meals.
* Personalized Treatment: This tablet offers a tailored solution for patients with varying degrees of Type 2 diabetes, facilitating better glycemic management.
Dosage and Administration: Evglip-M Tablet is taken once daily with food or as directed by your healthcare professional. Consistent adherence to the prescribed dosage regimen ensures optimal blood sugar control.
Important: This medication is not suitable for all individuals. Consult with a physician before starting any new treatment, especially if you have pre-existing conditions or are pregnant/breastfeeding.
Active composition
Vildagliptin 50 mg
+1 more active ingredient
About Vildagliptin
Vildagliptin is an anti-diabetic medication used to treat type 2 diabetes. It works by inhibiting the DPP-4 enzyme, which increases incretin levels and enhances insulin secretion. Vildagliptin is effective in managing blood sugar levels. Common side effects may include headache and nasopharyngitis, but these usually resolve over time. In summary, Vildagliptin is important for managing diabetes.
How It Works
Vildagliptin inhibits DPP-4, leading to increased levels of incretin hormones, which stimulate insulin secretion and decrease glucagon levels.
All Active Ingredients
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Eveglip-M Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Pregnancy
Eveglip-M Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Eveglip-M Tablet should be used with caution in patients with kidney disease. Dose adjustment of Eveglip-M Tablet may be needed. Please consult your doctor.
Exercise Caution
Breastfeeding
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Eveglip-M Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Eveglip-M Tablet
Products matching your search
Farostead Tablet
Farostead Tablet
Cefdron 100 Oral Suspension
Cefdron 100 Oral Suspension
Helmex 200mg Suspension
Helmex 200mg Suspension
Zeecent 500 Tablet
Zeecent 500 Tablet
Omniclav 625 Tablet
Omniclav 625 Tablet
Moxikem 500mg Capsule
Moxikem 500mg Capsule
Mox 250mg Capsule
Mox 250mg Capsule
Eritel CH 40 Tablet